MIR logo

MIRION TECHNOLOGIES INC

MIRNYSE
πŸ† #1396 by market capEarnings Feb 8 Β· PostUS Equity
$16.75β–² $1.34 (+8.70%)
πŸŒ™ After hours$16.60β–Ό 0.90%Regular close Β· extended-hours price shown
πŸ””
Track MIR
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 8.7%
7dβ–² 12.3%
14dβ–² 7.8%
30dβ–² 16.8%
ytdβ–Ό 28.4%
1yβ–Ό 43.7%
🏦Market Cap
$4.17B
Small Cap
πŸ“ˆRevenue Growth (YoY)
15.7%
Healthy
πŸ“ŠGross Margin
48.0%
Healthy
πŸ’΅FCF Margin
13.0%
Healthy
βš–οΈP/S Ratio
3.7x
Fair
Otter Score
60
Fair

Trading Snapshot

Day Range
$14.45 – $16.78
52-Week Range
$14.04 – $30.28
Volume (shares)
10,994,502
Avg Volume (shares)
β€”
Shares Outstanding
249.0M
Next Earnings
2027-02-08

Fundamentals Snapshot

Annual Revenue
$925M
Last Q Revenue
$267M
P/E Ratio
156.6
P/S Ratio
3.7x
EPS (TTM)
$0.09
Dividend Yield
β€”
Dilution (1yr)
+27.4%
MIR logo

MIRION TECHNOLOGIES INC

MIR
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$925Mβ–² +7.5% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
47.4%β–² +1.5% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$52Mβ–² +107.7% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$107Mβ–² +112.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
261.2Mβ–² +27.4% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$821Mβ–Ό βˆ’$277M YoY
StockOtter Β· stockotter.space

About MIRION TECHNOLOGIES INC

Mirion Technologies, Inc., established in 2005 and formerly known as Global Monitoring Systems, Inc. until its name change in January 2006, is based in Atlanta, Georgia. The company specializes in providing a comprehensive suite of specialized solutions for radiation detection, measurement, analysis, and monitoring. Its operations span a wide international footprint, covering countries such as the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, and Japan. The business is organized into two distinct operating segments: Medical and Industrial. The Medical segment delivers critical solutions aimed at enhancing patient safety and treatment accuracy within healthcare environments. Offerings here include quality assurance and dosimetry tools for radiation oncology, specialized patient safety systems for diagnostic imaging and radiation therapy centers, and precision calibration and verification solutions for medical imaging and treatment accuracy. Furthermore, it supplies radionuclide therapy products, which encompass shielding, handling equipment, dedicated medical imaging furniture, and rehabilitation aids for nuclear medicine applications. This segment fundamentally supports advancements in medical diagnostics, cancer treatment, professional safety for practitioners, and patient recovery. Conversely, the Industrial segment addresses vital requirements in radiation safety, measurement, and analysis across non-medical industries. It furnishes clients with personal radiation detection devices, identification equipment, and advanced analytical instrumentation. Mirion's extensive product and solution portfolio includes a variety of items such as nuclear medicine preparations, personal dosimeters, contamination and clearance monitoring systems, and sophisticated reactor instrumentation and control equipment. They also provide both medical and industrial imaging systems along with their related accessories, in addition to specialized instruments for alpha spectroscopy, alpha/beta counting, and gamma spectroscopy detector systems. Supplementary offerings include electrical penetration components, cancer diagnostic tools, software solutions, and a range of other services. Mirion serves a broad and varied clientele across numerous sectors. This includes healthcare providers like hospitals, clinics, urgent care facilities, dental and veterinary offices, and specialized radiation treatment centers, as well as original equipment manufacturers (OEMs) for radiation therapy. Beyond healthcare, their customers extend to research laboratories, military organizations, governmental agencies, various industrial enterprises, power and utility companies, reactor design firms, and nuclear power plants (NPPs).

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
60/100

Analyst Ratings

β“˜
Consensus
Buy
15 analysts
Strong Buy4
Buy9
Hold2
Sell0
Strong Sell0
Ratings as of Oct 2026

Latest News & Updates

Seeking AlphaΒ·6h ago

Mirion Technologies, Inc. (MIR) Q3 2026 Earnings Call Transcript

Mirion Technologies, Inc. ( MIR ) Q3 2026 Earnings Call October 28, 2026 10:00 AM EDT Company Participants Eric Linn - Vice President of Investor Relations Thomas Logan - Founder, Medical Group President, CEO & Chairman

MarketBeatΒ·6h ago

What Mirion Technologies (MIR) Said on Its Q3 Earnings Call

Mirion Technologies NYSE: MIR reported third-quarter revenue growth of 24.5% and sharply higher orders, citing accelerating demand from nuclear power customers and growing backlog conversion. The company also raised its

Zacks Investment ResearchΒ·1d ago

Mirion Technologies (MIR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Mirion Technologies (MIR) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and

Zacks Investment ResearchΒ·1d ago

Mirion Technologies, Inc. (MIR) Matches Q3 Earnings Estimates

Mirion Technologies, Inc. (MIR) came out with quarterly earnings of $0.12 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.12 per share a year ago.

Business WireΒ·1d ago

Mirion Announces Third Quarter 2026 Financial Results

ATLANTA--(BUSINESS WIRE)--Mirion (β€œwe” or the β€œcompany”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis, and monitoring solutions to the nuclear, medical, defense, and research end markets,

Business WireΒ·8d ago

Mirion Extends Support of IAEA Mission to Advance Cancer Care Globally through Rays of Hope Donation

ATLANTA--(BUSINESS WIRE)--Mirion, a leading provider of advanced radiation safety solutions, has announced support for the International Atomic Energy Agency (IAEA) Rays of Hope initiative, which aims to help address dis